approved EB-2 (NIW)

MD&PhD Student

Biomedical Science · Malaysia · 2022-03-05

Processing Time
170 days
Decision Date
2022-03-05
Location
Florida
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue investigating the underlying biology of cancer and establishing key biomarkers. This work aims to enhance patient outcomes through early detection and the development of targeted treatments.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The petitioner addressed nationally important topics in cancer biology and biomarker establishment.

2 Well-positioned to Advance the Endeavor Met

The petitioner's extensive research background, NIH funding, and high-impact publications demonstrate he is well-positioned.

3 Waiver Benefit Met

The petitioner's outsized impact on the field and degree of expertise far exceeding the ordinary justified the waiver of a job offer.

Why This Petition Was Approved

The case was approved based on the petitioner's 8 peer-reviewed journal articles and 5 conference publications which garnered 230 citations. Approval was further supported by NIH funding, memberships in the Society of Neuro-Oncology and the Congress of Neurological Surgeons, and service as a peer reviewer for professional journals.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Conference Presentations
Professional Memberships
Grants
Judging Experience
Original Contributions

Similar Cases

Postdoctoral Researcher

Biotechnology · Japan

WeGreened EB-2 (NIW) approved
54 days 2025-04-01
The petitioner proposes to develop advanced diagnostic and therapeutic approaches for cancer through biomarker identification and optimized combination therapies. This work focuses on enhancing early detection, personalizing treatment plans, and improving survival outcomes for cancer patients within the biotech and pharmaceutical industry.

Postdoctoral Researcher

Research and Development · India

WeGreened EB-2 (NIW) approved
New Jersey 173 days 2022-04-11
The petitioner proposes to systematically characterize genes and pathways involved in cancer development and progression using laboratory-based and animal models to study biological and clinical phenotypes. This work aims to identify novel molecular targets for cancer diagnosis, prognosis, and treatment modalities, specifically focusing on advanced breast cancer.

Others

Biotechnology · Poland

WeGreened EB-2 (NIW) approved
Massachusetts 290 days 2022-01-10
The petitioner proposes to create novel in vivo models to study cancer development, elucidate protein functions, and uncover the roles of transcriptomic machinery. This work aims to increase the understanding of cell cycle proteins critical for cancer growth to improve cancer treatments and immunotherapies.

Director

Healthcare · Turkey

WeGreened EB-2 (NIW) approved
Georgia 6 days 2023-10-02
The petitioner proposes to continue her research in translational pathology, specifically examining biobank data to investigate underlying cancer mechanisms. Her work focuses on identifying novel biomarkers to improve diagnostics, treatments, and patient outcomes for various forms of cancer.

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2022-03-05.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 170 days
Criteria Met 3 / 3
Evidence Types 7

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,816
Success Rate 53.6%
Sustained 2,046
Dismissed 1,674

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist